LONG-TERM CONTROLLED TRIAL WITH DIPHOSPHONATE IN PATIENTS WITH OSTEOLYTIC BONE METASTASES
- 1 January 1983
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 321 (8317), 146-149
- https://doi.org/10.1016/s0140-6736(83)92755-1
Abstract
Thirty-four normocalcaemic women with multiple osteolytic bone metastases from breast cancer were randomly allocated to treatment with disodium dichloromethylene diphosphonate (Cl2MDP) 1600 mg/day orally (17) or placebo (17) for 3-9 months. Fasting urinary hydroxyproline/creatinine and calcium/creatinine ratios declined in the Cl2MDP group but not in the placebo group. Four patients in the placebo group died from hypercalcaemia. New bone metastases were more common in patients on placebo and these patients also required more analgesic drugs than those on Cl2MDP. Cl2MDP seemed to reduce bone pain and bone resorption and prevent the development of hypercalcaemia caused by osteolytic metastases. The formation of new bone metastases and the growth of old ones seemed to be retarded by Cl2MDP.This publication has 18 references indexed in Scilit:
- Parenteral diphosphonates for treating malignant hypercalcemiaCancer, 1981
- EFFECT OF DICHLOROMETHYLENE DIPHOSPHONATE IN PAGET'S DISEASE OF BONE AND IN HYPERCALCÆMIA DUE TO PRIMARY HYPERPARATHYROIDISM OR MALIGNANT DISEASEThe Lancet, 1980
- Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases.JCI Insight, 1980
- Effects of Dichloromethylene Diphosphonate on Skeletal Mobilization of Calcium in Multiple MyelomaNew England Journal of Medicine, 1980
- INHIBITION OF OSTEOLYTIC BONE LESIONS BY (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (A.P.D.)The Lancet, 1979
- Calcium and cancerLife Sciences, 1978
- Mechanisms of bone destruction in the development of skeletal metastasesNature, 1976
- Evidence for the Secretion of an Osteoclast Stimulating Factor in MyelomaNew England Journal of Medicine, 1974
- Albumin standards and the measurement of serum albumin with bromcresol greenClinica Chimica Acta; International Journal of Clinical Chemistry, 1971
- Modifications of a specific assay for hydroxyproline in urineAnalytical Biochemistry, 1967